Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
Therapeutic Advances in Medical Oncology|November 26, 2020
Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinomaLuo Huang, Adelene Y L Sim, Yongzhong Wu, et al.Oral Oncology|February 20, 2021
Efficacy and safety of apatinib in recurrent/metastatic nasopharyngeal carcinoma: A pilot studyLuo Huang, Xin Zhang, Yu Bai, et al.Journal of Translational Medicine|April 30, 2024
Measurable residual disease monitoring by ddPCR in the early posttransplant period complements the traditional MFC method to predict relapse after HSCT in AML/MDS: a multicenter retrospective studyWeihao Chen, Jingtao Huang, Yeqian Zhao, et al.Therapeutic Advances in Medical Oncology|November 1, 2021
Development of a risk classification system combining TN-categories and circulating EBV DNA for non-metastatic NPC in 10,149 endemic casesFo-Ping Chen, Li Lin, Jin-Hui Liang, et al.ACS Applied Materials & Interfaces|November 28, 2025
Resolving Ternary Morphology for High-Performance Thickness-Insensitive Organic Solar CellsHeng Liu, Yuhao Li, Zhaoyang Nie, et al.International Journal of Radiation Oncology, Biology, Physics|April 10, 2020
A Prospective 10-Year Observational Study of Reduction of Radiation Therapy Clinical Target Volume and Dose in Early-Stage Nasopharyngeal CarcinomaJingjing Miao, Muping Di, Boyu Chen, et al.International Journal of Radiation Oncology, Biology, Physics|October 25, 2024
A Randomized, Multicenter, Phase 2 Trial of Camrelizumab With or Without Metastasis-directed Stereotactic Body Radiation Therapy in Recurrent or Metastatic Nasopharyngeal CarcinomaXin Zhang, Jin Yan, Qianqian Lei, et al.Cancer Letters|August 22, 2025
A multicenter, real-world study analysis: pembrolizumab changes treatment strategy for the patient with recurrent/metastatic head and neck squamous cell carcinomaMan Hu, Xia Li, Hong Feng, et al.International Journal of Radiation Oncology, Biology, Physics|June 17, 2020
High-Dimensional Characterization of the Systemic Immune Landscape Informs on Synergism Between Radiation Therapy and Immune Checkpoint BlockadeKevin L M Chua, Michael Fehlings, Eugenia L L Yeo, et al.Cell Reports. Medicine|May 24, 2025
Tumor immune microenvironment delineates progression trajectories of distinct nasopharyngeal carcinoma phenotypesEugenia Li Ling Yeo, Boon Hao Hong, Shi Hui Tay, et al.Pageof 9